On Target Laboratories: Making Light Work of Cancer Resection

article image

Surgeons' go-to means of sensing cancer uses only the hands and the naked eye, resulting in imperfect outcomes and more procedures, both diagnostic and interventional, down the line. On Target Laboratories has formulated a fluorescent marker that attaches to cancer cells to minimize uncertainty from detection and enable more complete resections.

Nearly everyone knows someone who has been diagnosed with cancer. Though patient outcomes vary and many do recover after a complete tumor removal, cancer is still a leading cause of death in the US, with lung, breast, and prostate accounting for the highest mortality rates.

Articles from Colin Miller:


Sky Medical: On the Pulse of Clot Prevention

Stroke survivors and recent surgical patients face an elevated risk of blood clot formation in the lower legs, as decreased mobility diminishes the ability of the body's natural compression system to pump blood out of deep leg veins. Low compliance rates, discomfort, and limited effectiveness detract from external compression, the current standard of clot prevention, leading Sky Medical to meet the market's need with a bioelectronic device that electrically stimulates motor neurons.

Read Article